News Website

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers TradingView

Published: May 7, 2026, 12:05 p.m.

Read Full Article

FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan

FDA clears new dual-target cancer drug for ovarian, endometrial trial Stock Titan

Published: May 7, 2026, 12:02 p.m.

Read Full Article

Metabolomic Markers of Neurotransmitter-Related Metabolism in Women with Ovarian Endometriomas: The Role of the Kynurenine Pathway and Changes During Progestin Therapy - EMJ

Metabolomic Markers of Neurotransmitter-Related Metabolism in Women with Ovarian Endometriomas: The Role of the Kynurenine Pathway and Changes During Progestin Therapy EMJ

Published: April 30, 2026, 6:19 a.m.

Read Full Article

Bowel and Ovarian Cancer Cases Rise Among U.K. Young Adults - Inside Precision Medicine

Bowel and Ovarian Cancer Cases Rise Among U.K. Young Adults Inside Precision Medicine

Published: April 29, 2026, 5:51 p.m.

Read Full Article

Young Adults in England Face Rising Bowel, Ovarian Cancers - Mirage News

Young Adults in England Face Rising Bowel, Ovarian Cancers Mirage News

Published: April 29, 2026, 8:20 a.m.

Read Full Article

Bowel And Ovarian Cancer Rates Are Only Rising For Under-50s, Study Finds - HuffPost UK

Bowel And Ovarian Cancer Rates Are Only Rising For Under-50s, Study Finds HuffPost UK

Published: April 28, 2026, 11:01 p.m.

Read Full Article

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review - CancerNetwork

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review CancerNetwork

Published: April 27, 2026, 10:49 a.m.

Read Full Article

Mo-Rez shows strong early responses in ovarian, endometrial cancers - Rare Cancer News

Mo-Rez shows strong early responses in ovarian, endometrial cancers Rare Cancer News

Published: April 22, 2026, 4:40 p.m.

Read Full Article

High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN

Published: April 20, 2026, 8:14 a.m.

Read Full Article

'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' - The Mirror

'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' The Mirror

Published: April 19, 2026, 6 a.m.

Read Full Article

Latest Articles

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan

Metabolomic Markers of Neurotransmitter-Related Metabolism in Women with Ovarian Endometriomas: The Role of the Kynurenine Pathway and Changes During Progestin Therapy - EMJ

Bowel and Ovarian Cancer Cases Rise Among U.K. Young Adults - Inside Precision Medicine

Young Adults in England Face Rising Bowel, Ovarian Cancers - Mirage News

Bowel And Ovarian Cancer Rates Are Only Rising For Under-50s, Study Finds - HuffPost UK

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review - CancerNetwork

Mo-Rez shows strong early responses in ovarian, endometrial cancers - Rare Cancer News

High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

'I'm a gynaecologist and there's hidden ovarian cancer symptom you must never ignore' - The Mirror

Subscribe to Our Newsletter